Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Major innovation in fight against pleural cancer

05 Apr 2016 | Health Nutrition, A region on the move

Lille hospital plays a key role in new treatment for pleural cancer.

For over 10 years, medicine had made no progress in treating cancer of the pleura, the membrane lining the lungs.

But now the Bio-MAPS program, launched by Dr. Gérard Zalcman in close cooperation with 70 French hospital groups, has shown that Bevacizumab is effective in treating pleural cancer, significantly reducing mortality risk in 23% of patients who were treated with it.

Dr. Arnaud Scherpereel, head of pulmonology and thoracic oncology at Lille University Hospital Center (CHRU) and coordinator of the Bevacizumab project, stresses that the treatment is equally effective in all patient sub-groups, including those with the worst prognosis factors.

As a result, this new treatment solution is becoming the first-line therapy for patients with pleural cancer.

Back to news


Investments and new products point to sweet times ahead for Carambar

Sales are up at Carambar, the iconic toffee stick maker based in Hauts-de-France and acquired by Eurazeo in 2016. Coming soon: a major investment program and new flavors.

Heineken invests €8 million at Hauts-de-France site

Dutch brewer Heineken continues to expand in France and is now set to invest €20m in its three French sites in 2018. That includes €8.3m earmarked for its largest French brewery, located in Hauts-de-France.

All news